BAC
Bank of America Corporation
BAC has a slight edge over MC overall, supported by stronger fundamentals and lower modeled downside.
MC
Moelis & Company
MC offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
MC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
MC's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like MC.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over MC in the historical PE scenario, which offers more potential upside but is not a forecast.
MC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $35.85 | -36% |
| Forward | 16x | $56.01 | — |
| Current | 19x | $56.01 | — |
| Fair | 20x | $60.15 | +7.4% |
| Expensive | 38x | $112 | +101% |
Historical ranges are pointers, not guarantees.
MC's PE is in its fair range at 19x. If earnings grow as analysts expect, today's price would be 16x next year's earnings.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
MC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for MC, with profitability improving. However, they disagree widely on these estimates.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over MC on earnings, with more consistent year-over-year improvement.
MC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.55 | +21% |
| Q3 2026 | $2.94 | -1.7% |
| Q2 2026 | $2.87 | +13% |
| Q1 2026 | $2.78 | +28% |
| Q4 2025 | $2.94 | +67% |
| Q3 2025 | $2.99 | +464% |
| Q2 2025 | $2.54 | +1593% |
| Q1 2025 | $2.18 | +$2.37 |
| Q4 2024 | $1.76 | +$2.12 |
MC's earnings per share have fallen from their peak: $2.94 over the past year, against $5.90 in late 2021.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over MC on profitability, with a higher operating margin.
MC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $409.4M | +12% |
| Q1 2026 | $319.8M | +4.3% |
| Q4 2025 | $487.9M | +11% |
| Q3 2025 | $356.9M | +30% |
| Q2 2025 | $365.4M | +38% |
| Q1 2025 | $306.6M | +41% |
| Q4 2024 | $438.7M | +104% |
| Q3 2024 | $273.8M | +0.6% |
MC has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 18% | +1.2 points |
| Q1 2026 | 13% | +0.6 points |
| Q4 2025 | 26% | -3.8 points |
| Q3 2025 | 14% | +7.8 points |
| Q2 2025 | 17% | +9 points |
| Q1 2025 | 12% | +9.4 points |
| Q4 2024 | 30% | +34 points |
| Q3 2024 | 5.7% | +13 points |
MC's operating margin was 18% last quarter, up 1.2 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
MC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $250.2M | +39% |
| Q2 2026 | $218M | +9.3% |
| Q1 2026 | -$291.6M | -$123M |
| Q4 2025 | $329.6M | +5.3% |
| Q3 2025 | $179.6M | +33% |
| Q2 2025 | $199.4M | +45% |
| Q1 2025 | -$168.6M | +$1.8M |
| Q4 2024 | $313M | +233% |
MC has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over MC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
MC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -1.4M shares |
| 1 year | -1.3% | -994K shares |
| 3 years | +14% | +9.3M shares |
| 5 years | +14% | +9.8M shares |
| Available history | +39% | +21.7M shares |
MC has 78M diluted shares, down 1.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $23.5M |
| Q1 2026 | $117.3M |
| Q4 2025 | $46.1M |
| Q3 2025 | $15.2M |
| Q2 2025 | $1.6M |
| Q1 2025 | $11.6M |
| Q4 2024 | $1.1M |
| Q3 2024 | $1M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
MC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | 0.2x | Very low |
| Q4 2024 | -1.0x | Net Cash |
MC has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
MC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 30.3 | Neutral |
MC's weekly RSI is 39 (neutral) and its Stochastic is 30 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over MC on valuation relative to its sector.
MC PE vs Financial Services Sector
| Metric | MC | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 13x | 46% above |
| PE % | 44 | 63 | 19 pts below |
MC is trading at 19x earnings, a 46% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has the edge over MC on trend strength, trading above more of its moving averages.
MC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.6 | 1% below |
| 20 week MA | $62.6 | 10% below |
| 50 week MA | $64.5 | 13% below |
| 100 week MA | $65.3 | 14% below |
| 200 week MA | $59.0 | 5.1% below |
MC is in a downtrend: it's below all five of its weekly moving averages, and 5.1% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over MC on returns for 2026, with the stronger performance.
MC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.8 | $47.2 | +44% |
| 2021 | $47.2 | $62.4 | +32% |
| 2022 | $62.4 | $39.0 | -37% |
| 2023 | $39.0 | $56.1 | +44% |
| 2024 | $56.1 | $74.5 | +33% |
| 2025 | $74.5 | $71.6 | -3.9% |
| 2026 YTD | $71.6 | $56.0 | -22% |
MC has finished higher in four of the last six years. It's down 22% so far in 2026.